advanced search

Welcome: Guest

log in

Drug Testing: Technologies and Global Markets

Publication Date July 2008
Publisher BCC Research
Product Type Report
Pages
ISBN Number not applicable
Product Code BCC00230
Price

£3,265.00
approximately: $4,849 | €3,842

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

Study Goal And Objectives

The Purpose Of This Study Is To Analyze The Market For Drugs Of Abuse (Doa) Testing Globally And To Provide Market, Technology, And Revenue Forecasts For The Period 2008 To 2014. This Report Also Analyzes The Global Environment Related To Regulations, National Level Policies, And Legislation In Several Parts Of The World That Affect Doa Testing Markets.

This Bcc Report Provides An In-Depth Look At Doa Testing Markets, Which Had Sales Of More Than $1.9 Billion In 2007. Future Growth Prospects Of This Market By Various Sample Matrices Have Been Analyzed Based On Market Dynamics, Technology Efficacies, And Regulatory Factors. Regional Analysis Of The Industry In Terms Of Current And Future Trends Of Drug Abuse And Testing Practices In Important Regions Has Been Presented In The Study. The Report Also Identifies Key Market Players With Significant Market Shares, Analyzes Current And Future Strategies Of These Companies That Will Have An Impact In The Market, And Analyzes Future Growth Trends. Key Companies Participating In This Market Are Profiled.

This Report Also Analyzes The Current And Possible Future Legislations Affecting The Market In The U.S. And Other Countries, And Examines The Influence Of These Acts In The Development Of The Industry. Finally, Several Testing Technologies Have Been Discussed And Testing Trends With Respect To Various Sample Matrices Have Been Presented In The Report, Identifying The Likely Trends In The Foreseeable Future.

Reasons For Doing The Study

Bcc Published A Comprehensive Report On Doa Testing In 2002. Since Then, The Doa Industry Has Undergone Many Noteworthy Changes. One Key Factor That Was Instrumental In These Changes Is The Extensive Growth Of Narcotics Markets And Consequently Governmental Initiatives And Efforts To Combat And Eradicate These Markets, Not Only In Favor Of Crimes Related To The Narcotics, But Also To Ensure Quality In The Social Structure Within The Nation. This Has Led The Regulatory Framework In Several Countries To Undergo Changes And Evolve Over Time To Address Drug Production And Trafficking.

This Report Analyzes The Current And Emerging Trends In The Market. In Addition, It Also Analyzes Regulatory Issues For Several Countries Related To Drug Trafficking And Abuse That Illustrate The Nation's Stand On Narcotics And Its Awareness Among The Masses That Potentially Affects Doa Testing Sales Within These Markets.

Intended Audience

This Study Offers Insight Into The Successful Strategies Adopted By Companies That Helped Them Improve Their Market Shares In The Doa Testing Markets. High-Growth Markets In Terms Of Geographic Regional Growth Trends For Various Sample Matrices For Drug Of Abuse Testing Are Identified. Strategies Adopted By Big In Vitro Diagnostic Companies As Well As Small Innovative Diagnostic Companies Entering The Market Have Been Identified. These Detailed Analyses Are Targeted To Assist Developers And Decision Makers Of Healthcare Diagnostics Companies. The Report Includes Detailed Analyses Of The Regulatory Factors That Have Been Instrumental In Driving The Industry In Developed Countries. This Is Especially Suitable For Legislators Involved In Government Policy Development Programs. Technology Trend Analysis Gives An Overview Of Successful Technologies, Which Is Helpful For Research Managers In Charge Of Project Identification And Development.

Scope Of Report

This Report Contains:

  • An Overview Of Drug Abuse Trends In Terms Of Various Geographic Regions As Well As Drug Classes.
  • Drug Abuse Statistics In Key Regions.
  • Analysis Of Regulatory Environments In North, South And Central America, Europe, And Asia Pacific, And Country-Wise Summaries Of National Legislation And Policies.
  • Drug Of Abuse Testing Markets With Respect To Testing Approaches And Sample Matrices.
  • Technology Trends In The Drug Of Abuse Testing Market.
  • Leading Players In The Market And Their Key Products.
  • Sales Projections Through 2014 For Drug Of Abuse Testing Markets By Sample Matrix And Geographic Regions.
  • Analysis Of Leading Companies And Their Successful Strategies.

Methodology

The Base Year Of This Study Is 2007. Market Figures Are Based On The Revenues At The Manufacturer's Level And Are Projected At 2007 Dollar Value (I.E., Inflation Is Not Computed Into The Projection Figures). Forecasts Are Mainly Based On The Projections Of The Marketers. Growth Of Competing Products, Technologies, Drug Of Abuse Growth Trends, Government Policies, And Trends In The In Vitro Diagnostics (Ivd) Market Have Also Been Considered For Estimating The Future Growth Trends.

Data To Prepare This Study Was Derived From Regulatory Agencies, Trade Literature, Patient Support Groups, And Annual Reports Of Companies And Industry Related Databases. In Addition, Discussion With Product Managers Of Diagnostic Companies, Research Executives, Academic Researchers, And Government Agency Spokespersons Have Been Conducted For Gaining Insights About The Market, Strategies, And Future Trends.

Information Sources

The Information And Analysis Presented In This Report Are Based On An Extensive Survey Of The Doa Industry As Well As A Detailed Examination Of Published Literature And Reports Obtained From Regulatory Authorities, Medical Research Institutions, Trade Associations, And National And World Health Organizations. Key Information From The Literature Was Used To Obtain Expert Opinions On Commercial Potential And Market Sizes From Industry Professionals.

Content

  • Summary Table Global Drugs Of Abuse Testing Market
  • Summary Figure Global Drugs Of Abuse Testing Market
  • Overview
  • Drug Abuse Testing
  • Introduction
  • International Drug Trafficking And Illicit
  • Drug Use Trends By Drug Type
  • Table Number Of Illicit Drug Users Globally, 20032007
  • (Millions)
  • Table Global Drug Seizures By Country, Drug Type,
  • And Quantity, Januaryjune, 2007
  • Amphetamine-Type Stimulants Market
  • Cannabis Market
  • Coca/Cocaine Market
  • Table Global Illicit Cultivation Of Coca/Cocaine, 2000
  • 2007 (Mt)
  • Opium/Heroin Market
  • Table Global Illicit Cultivation Of Opium, 20002007
  • (Mt)
  • International Drug Trafficking And Illicit
  • Drug Use Trends By Geographic Region
  • Africa
  • Central America And Caribbean
  • North America
  • South America
  • East And Southeast Asia
  • South Asia
  • West Asia
  • Europe
  • Oceania
  • U.S. Drugs Of Abuse Statistics
  • National Household Survey On Drug Abuse: Samhsa
  • U.S
  • Survey By Age And Drug Type
  • Table Drug Abuse Statistics In The U.S. By Drug Type (
  • Yrs And Older), 2005 And 2006 (Thousands)
  • Survey By Age
  • Table Illicit Drug Use In Lifetime Among Persons
  • Yrs And Older In The U.S. By Age, 2005 And 2006
  • (Thousands)
  • Survey By Gender And Drug Type
  • Table Types Of Illicit Drug Use In Lifetime Among
  • Persons Yrs And Older In The U.S. By Gender, 2005
  • And 2006 (Thousands)
  • Survey By Race And Ethnicity
  • Table Illicit Drug Use In Lifetime Among Persons
  • Yrs And Older In The U.S. By Race And Ethnicity, 2005
  • And 2006 (Thousands)
  • Survey By Geographic Divisions And County Types
  • Table Illicit Drug Use In Lifetime Among Persons Aged
  • Or Older In The U.S. By Geographic Divisions And
  • County Types 2005 And 2006 (Thousands)
  • Survey By Education And Current Employment
  • Status
  • Table Illicit Drug Use In Lifetime Among Persons
  • Aged Or Older By Education And Employment, 2005
  • And 2006 (Thousands)
  • Table U.S. Workforce Annual Drugs Of Abuse
  • Positivity Rate, 19902003 (%)
  • Drugs Of Abuse Statistics, Australia
  • Table Proportion Of Australian Population Using
  • Illicit Drugs Aged Years And Over By Drug Type,
  • 1995-2007 (%)
  • Drugs Of Abuse Statistics, Central Asia
  • Table Drug Abuse Statistics In Central Asia, 2006
  • Drugs Of Abuse Testing Practices
  • Single Vs Multi-Parameter Test
  • Doa Screening
  • Confirmation Testing
  • Urine Tests
  • Other Testing Methods
  • Blood Testing
  • Oral Fluid Testing
  • Saliva Testing
  • Sweat Testing
  • Hair Testing
  • Testing Locations
  • Laboratory-Based Dat
  • Criminal Justice
  • Police
  • Prisons
  • Probation
  • Workplace Screening
  • Military
  • Customs And Excise
  • Education
  • Point Of Care Dats
  • Table Advantages And Disadvantages Of Point Of
  • Care Testing
  • Onsite Testing Vs Laboratory Testing
  • Table Major Advantages And Disadvantages Of
  • Onsite Testing
  • Sample Types For Laboratory Testing
  • Urine Testing
  • Hair Testing
  • Saliva/Oral Fluid Testing
  • Blood Testing
  • Sweat Testing
  • Detection Period
  • Table Detection Periods For Various Types Of Drug
  • Testing
  • Fooling A Drug Test
  • Fooling Urine Testing
  • Table Common Parameters Tested For Urine Specimen
  • Validity
  • Table Some Of The Commercial/Common Adulterants
  • Used In Fooling Urine Tests And Their Effects
  • Fooling Hair Testing
  • Fooling Saliva Testing
  • Sample Validity Tests
  • Table Urine Sample Validity Test Methods
  • False Positives And False Negatives
  • False Positives
  • Table Cross Reactants That Can Lead To False
  • Positives In Doa Testing
  • False Negatives
  • Testing Technologies
  • Immunoassays
  • Enzyme Immunoassay (Eia)
  • Enzyme-Linked Immunosorbent Assay (Elisa)
  • Enzyme Multiplied Immunoassay Technology
  • Fluorescence Polarization Immunoassay (Fpia)
  • Radioimmunoassay (Ria)
  • Chromatography
  • Gas Chromatography (Gc)
  • High Performance Liquid Chromatography (Hplc)
  • Thin-Layer Chromatography (Tlc)
  • Mass Spectrometry (Ms)
  • Capillary Electrophoresis (Ce)
  • Hyphenated Ms/Chromatography
  • Gas-Chromatography-Mass Spectrometry
  • Eye Reflex Measurements
  • Eye Reflex Measurements (Continued)
  • Government Regulations: Drug Trafficking And Drug
  • Abuse Testing
  • North America
  • National Legislation And Policy
  • Canada
  • Drug Free Workplace
  • Mexico
  • The United States
  • Drug-Free Workplace
  • Table U.S. Drug Testing Legislations By State, 2008
  • U.S. Department Of Transportation
  • Drug Testing In The Military
  • South America
  • National Legislation And Policy
  • Bolivia
  • Brazil
  • Drug-Free Workplace
  • Colombia
  • Ecuador
  • Guyana
  • Paraguay
  • Peru
  • Central America And The Caribbean
  • National Legislation And Policy
  • Costa Rica
  • Cuba
  • El Salvador
  • Guatemala
  • Jamaica
  • Nicaragua
  • Panama
  • Tegucigalpa
  • The Bahamas
  • The Netherlands Antilles
  • Trinidad And Tobago
  • Europe
  • National Legislation And Policy
  • Bosnia And Herzegovina
  • Denmark
  • France
  • Germany
  • Italy
  • Latvia
  • Norway
  • Romania
  • Sweden
  • Switzerland
  • The Netherlands
  • The United Kingdom
  • Drug-Free Workplace Policy And Legislation By
  • European Country
  • Table Drug-Testing Legislation By European
  • Country, 2008
  • Asia Pacific
  • National Legislation And Policy
  • Australia
  • Bangladesh
  • Bhutan
  • Cambodia
  • Hong Kong
  • India
  • The Ndps (Regulation Of Controlled Substances)
  • Order, 1993
  • Japan
  • Maldives
  • Myanmar
  • Nepal
  • New Zealand
  • Singapore
  • South Korea
  • Sri Lanka
  • Taiwan
  • Thailand
  • Vietnam
  • Drugs Of Abuse Testing Sales
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Sample Matrix, Through 2014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Sample Matrix, 20062014 ($ Millions)
  • Global Sales Of Drugs Of Abuse Testing By Urine
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine, Through 2014 ($ Millions/%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine, 20062014 ($ Millions)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine: Laboratory Based Versus Onsite,
  • Through 2014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine: Laboratory Based Versus Onsite,
  • 2007 (%)
  • Global Sales Of Drugs Of Abuse Testing By Blood
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Blood, Through 2014 ($ Millions/%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Blood, 20062014 ($ Millions)
  • Global Sales Of Drugs Of Abuse Testing By Oral Fluid
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral Fluid, Through 2014 ($ Millions/%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral Fluid, 20062014 ($ Millions)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral Fluid: Laboratory Based Versus
  • Onsite, Through 2014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral: Laboratory Based Versus Onsite, 2006
  • And 2014 (%)
  • Global Sales Of Drugs Of Abuse Testing By Hair
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Hair, Through 2014 ($ Millions/%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Hair, 20062014 ($ Millions)
  • Global Sales Of Drugs Of Abuse Testing By Sweat
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Sweat, Through 2014 ($ Millions/%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Sweat, 20062014 ($ Millions)
  • Global Sales Of Drugs Of Abuse Testing By Other
  • Sample Matrices
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Other Sample Matrices, Through 2014
  • ($ Millions/%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Other Sample Matrices, 20062014
  • ($ Millions)
  • Worldwide Industry Structure
  • Regional Analysis
  • Figure Drugs Of Abuse Testing Markets By
  • Geographic Regions, 2007 (%)
  • Figure
  • Total Doa Testing And Drug Monitoring Markets And
  • Forecasts
  • Table Global Drugs Of Abuse Testing Market
  • Forecast, Through 2014 ($ Millions/%)
  • Table Drugs Of Abuse Testing By Laboratory, Onsite,
  • And Home Testing Market Forecast, 20062014
  • ($ Millions/%)
  • Growth Trendslaboratory Based And Onsite Doa
  • Testing Markets
  • Laboratory-Based Doa Testing Markets And
  • Forecasts
  • Table Drugs Of Abuse Testing Market Forecast For
  • Laboratory-Based Testing, 20062014 ($ Millions/%)
  • Onsite Doa Testing Markets And Forecasts
  • Table Drugs Of Abuse Testing Market Forcast For
  • Onsite Testing, Through 2014 ($ Millions/%)
  • Competitive Analysis
  • Table Most Notable Mergers And Acquisitions In The
  • Doa Testing Markets, 20002007
  • Key Market Players In The Doa Testing Markets And
  • Their Products
  • Table Major Companies And Their Products In The
  • Doa Testing Market
  • Laboratory-Based Doa Testing Market Segment
  • Table Companies Offering Laboratory-Based Doa
  • Testing Products
  • Onsite Testing Market Segment For Doa
  • Table Main Onsite Doa Testing Market Players And
  • Their Products
  • Common Drugs Of Abuse And Most Popular
  • Devices Used For Testing Them
  • Table Common Doa And Popular Urine Drug Screening
  • Products
  • Companies In The Oral Fluid, Hair, And Sweat
  • Testing Segments For Doa
  • Table Key Market Players Offering Doa Testing
  • Products On Oral Fluid, Hair, And Sweat Sample
  • Matrices
  • Company Profiles
  • Abbott Laboratories
  • Abbott Hematologydiagnostics Division
  • Acon Laboratories, Inc
  • American Bio Medica Corp. (Abmc)
  • Avitar, Inc
  • Beckman Coulter
  • Bio-Rad Laboratories, Inc
  • Concateno, Plc
  • F. Hoffmann-La Roche, Ltd
  • Inverness Medical Innovations, Inc
  • Medtox Scientific, Inc
  • Microgenics
  • Nanogen, Inc
  • Olympus Diagnostics Systems
  • Orasure Technologies, Inc
  • Siemens Medical Solutions Usa, Inc
  • Varian, Inc
  • Varian, Inc. (Continued)
  • Patent Analysis
  • Table U.S. Drugs Of Abuse Testing Patents By
  • Assignee, 19782007
  • Table Glossary Of Common Terms
  • Table Glossary Of Scientific Abbreviations
  • Table Associations
  • List Of Tables
  • Summary Table Global Drugs Of Abuse Testing Market
  • Table Number Of Illicit Drug Users Globally, 20032007
  • (Millions)
  • Table Global Drug Seizures By Country, Drug Type, And
  • Quantity, Januaryjune, 2007
  • Table Global Illicit Cultivation Of Coca/Cocaine, 2000
  • 2007 (Mt)
  • Table Global Illicit Cultivation Of Opium, 20002007 (Mt)
  • Table Drug Abuse Statistics In The U.S. By Drug Type (
  • Yrs And Older), 2005 And 2006 (Thousands)
  • Table Illicit Drug Use In Lifetime Among Persons Yrs
  • And Older In The U.S. By Age, 2005 And 2006 (Thousands)
  • Table Types Of Illicit Drug Use In Lifetime Among
  • Persons Yrs And Older In The U.S. By Gender, 2005 And
  • 2006 (Thousands)
  • Table Illicit Drug Use In Lifetime Among Persons Yrs
  • And Older In The U.S. By Race And Ethnicity, 2005 And 2006
  • (Thousands)
  • Table Illicit Drug Use In Lifetime Among Persons Aged
  • Or Older In The U.S. By Geographic Divisions And County
  • Types 2005 And 2006 (Thousands)
  • Table Illicit Drug Use In Lifetime Among Persons Aged
  • Or Older By Education And Employment, 2005 And 2006
  • (Thousands)
  • Table U.S. Workforce Annual Drugs Of Abuse Positivity
  • Rate, 19902003 (%)
  • Table Proportion Of Australian Population Using
  • Illicit Drugs Aged Years And Over By Drug Type, 1995-
  • 2007 (%)
  • Table Drug Abuse Statistics In Central Asia, 2006
  • Table Advantages And Disadvantages Of Point Of Care
  • Testing
  • Table Major Advantages And Disadvantages Of Onsite
  • Testing
  • Table Detection Periods For Various Types Of Drug
  • Testing
  • Table Common Parameters Tested For Urine Specimen
  • Validity
  • List Of Tables
  • Table Some Of The Commercial/Common Adulterants
  • Used In Fooling Urine Tests And Their Effects
  • Table Urine Sample Validity Test Methods
  • Table Cross Reactants That Can Lead To False Positives
  • In Doa Testing
  • Table U.S. Drug Testing Legislations By State, 2008
  • Table Drug-Testing Legislation By European Country,
  • 2008
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Sample Matrix, Through 2014 ($ Millions)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine, Through 2014 ($ Millions/%)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine: Laboratory Based Versus Onsite,
  • Through 2014 ($ Millions)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Blood, Through 2014 ($ Millions/%)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral Fluid, Through 2014 ($ Millions/%)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral Fluid: Laboratory Based Versus Onsite,
  • Through 2014 ($ Millions)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Hair, Through 2014 ($ Millions/%)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Sweat, Through 2014 ($ Millions/%)
  • Table Global Sales Forecast For Drugs Of Abuse
  • Testing By Other Sample Matrices, Through 2014
  • ($ Millions/%)
  • Table Global Drugs Of Abuse Testing Market Forecast,
  • Through 2014 ($ Millions/%)
  • Table Drugs Of Abuse Testing By Laboratory, Onsite,
  • And Home Testing Market Forecast, 20062014
  • ($ Millions/%)
  • Table Drugs Of Abuse Testing Market Forecast For
  • Laboratory-Based Testing, 20062014 ($ Millions/%)
  • Table Drugs Of Abuse Testing Market Forcast For
  • Onsite Testing, Through 2014 ($ Millions/%)
  • Table Most Notable Mergers And Acquisitions In The
  • Doa Testing Markets, 20002007
  • List Of Tables
  • Table Major Companies And Their Products In The Doa
  • Testing Market
  • Table Companies Offering Laboratory-Based Doa
  • Testing Products
  • Table Main Onsite Doa Testing Market Players And
  • Their Products
  • Table Common Doa And Popular Urine Drug Screening
  • Products
  • Table Key Market Players Offering Doa Testing
  • Products On Oral Fluid, Hair, And Sweat Sample
  • Matrices
  • Table U.S. Drugs Of Abuse Testing Patents By Assignee,
  • 19782007
  • Table Glossary Of Common Terms
  • Table Glossary Of Scientific Abbreviations
  • Table Associations
  • List Of Figures
  • Summary Figure Global Drugs Of Abuse Testing
  • Market Forecast By Region, 20062014
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Sample Matrix, 20062014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine, 20062014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Urine: Laboratory Based Versus Onsite, 2007
  • (%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Blood, 20062014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral Fluid, 20062014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Oral: Laboratory Based Versus Onsite, 2006
  • And 2014 (%)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Hair, 20062014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Sweat, 20062014 ($ Millions)
  • Figure Global Sales Forecast For Drugs Of Abuse
  • Testing By Other Sample Matrices, 20062014 ($ Millions)
  • Figure Drugs Of Abuse Testing Markets By Geographic
  • Regions, 2007 (%)